These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 12445678

  • 1. Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment.
    Schwarz RE, Donohue CA, Sadava D, Kane SE.
    Cancer Lett; 2003 Jan 10; 189(1):59-68. PubMed ID: 12445678
    [Abstract] [Full Text] [Related]

  • 2. PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo .
    Kubota T, Hisatake J, Hisatake Y, Said JW, Chen SS, Holden S, Taguchi H, Koeffler HP.
    Prostate; 2000 Feb 15; 42(3):163-71. PubMed ID: 10639186
    [Abstract] [Full Text] [Related]

  • 3. PC-SPES inhibits colon cancer growth in vitro and in vivo.
    Huerta S, Arteaga JR, Irwin RW, Ikezoe T, Heber D, Koeffler HP.
    Cancer Res; 2002 Sep 15; 62(18):5204-9. PubMed ID: 12234985
    [Abstract] [Full Text] [Related]

  • 4. Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer.
    Damaraju VL, Bouffard DY, Wong CK, Clarke ML, Mackey JR, Leblond L, Cass CE, Grey M, Gourdeau H.
    BMC Cancer; 2007 Jul 03; 7():121. PubMed ID: 17608948
    [Abstract] [Full Text] [Related]

  • 5. Contaminants of PC-SPES are not responsible for cytotoxicity in human small-cell lung carcinoma cells.
    Sadava D, Winesburg J.
    Cancer Lett; 2005 Apr 08; 220(2):171-5. PubMed ID: 15766592
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells.
    Hsieh TC, Wu JM.
    Int J Oncol; 2002 Mar 08; 20(3):583-8. PubMed ID: 11836572
    [Abstract] [Full Text] [Related]

  • 7. In vitro mechanism of PC SPES.
    Chenn S.
    Urology; 2001 Aug 08; 58(2 Suppl 1):28-35; discussion 38. PubMed ID: 11502443
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effects of PC-Spes on chemosensitive and chemoresistant head and neck cancer cells and primary mucosal keratinocytes.
    Schmidt M, Polednik C, Gruensfelder P, Roller J, Hagen R.
    Oncol Rep; 2009 May 08; 21(5):1297-305. PubMed ID: 19360307
    [Abstract] [Full Text] [Related]

  • 10. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
    Bigler D, Gulding KM, Dann R, Sheabar FZ, Conaway MR, Theodorescu D.
    Oncogene; 2003 Feb 27; 22(8):1261-72. PubMed ID: 12606954
    [Abstract] [Full Text] [Related]

  • 11. Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition.
    Bonham MJ, Galkin A, Montgomery B, Stahl WL, Agus D, Nelson PS.
    J Natl Cancer Inst; 2002 Nov 06; 94(21):1641-7. PubMed ID: 12419791
    [Abstract] [Full Text] [Related]

  • 12. Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients.
    de la Taille A, Hayek OR, Buttyan R, Bagiella E, Burchardt M, Katz AE.
    BJU Int; 1999 Nov 06; 84(7):845-50. PubMed ID: 10532984
    [Abstract] [Full Text] [Related]

  • 13. Isodon eriocalyx and its bioactive component Eriocalyxin B enhance cytotoxic and apoptotic effects of gemcitabine in pancreatic cancer.
    Li L, Zhao SL, Yue GGL, Wong TP, Pu JX, Sun HD, Fung KP, Leung PC, Han QB, Lau CBS, Leung PS.
    Phytomedicine; 2018 May 15; 44():56-64. PubMed ID: 29895493
    [Abstract] [Full Text] [Related]

  • 14. Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer.
    Bianco C, Giovannetti E, Ciardiello F, Mey V, Nannizzi S, Tortora G, Troiani T, Pasqualetti F, Eckhardt G, de Liguoro M, Ricciardi S, Del Tacca M, Raben D, Cionini L, Danesi R.
    Clin Cancer Res; 2006 Dec 01; 12(23):7099-107. PubMed ID: 17145834
    [Abstract] [Full Text] [Related]

  • 15. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer.
    DiPaola RS, Zhang H, Lambert GH, Meeker R, Licitra E, Rafi MM, Zhu BT, Spaulding H, Goodin S, Toledano MB, Hait WN, Gallo MA.
    N Engl J Med; 1998 Sep 17; 339(12):785-91. PubMed ID: 9738085
    [Abstract] [Full Text] [Related]

  • 16. Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.
    Bernhaus A, Ozsvar-Kozma M, Saiko P, Jaschke M, Lackner A, Grusch M, Horvath Z, Madlener S, Krupitza G, Handler N, Erker T, Jaeger W, Fritzer-Szekeres M, Szekeres T.
    Invest New Drugs; 2009 Oct 17; 27(5):393-401. PubMed ID: 18841326
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes.
    Shi X, Liu S, Kleeff J, Friess H, Büchler MW.
    Oncology; 2002 Oct 17; 62(4):354-62. PubMed ID: 12138244
    [Abstract] [Full Text] [Related]

  • 19. Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer.
    de la Taille A, Buttyan R, Hayek O, Bagiella E, Shabsigh A, Burchardt M, Burchardt T, Chopin DK, Katz AE.
    J Urol; 2000 Oct 17; 164(4):1229-34. PubMed ID: 10992371
    [Abstract] [Full Text] [Related]

  • 20. Prevention and management of prostate cancer using PC-SPES: a scientific perspective.
    Hsieh TC, Lu X, Chea J, Wu JM.
    J Nutr; 2002 Nov 17; 132(11 Suppl):3513S-3517S. PubMed ID: 12421879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.